Clonidine as analgesia during retinopathy of prematurity screening in preterm infants (cloROP): protocol for a randomised controlled trial

Martina Carlsen Misic, Mats Eriksson, Erik Normann, Miriam Pettersson, Ylva Blomqvist, Emma Olsson, Martina Carlsen Misic, Mats Eriksson, Erik Normann, Miriam Pettersson, Ylva Blomqvist, Emma Olsson

Abstract

Introduction: Preterm infants are at risk of negative consequences from stress and pain at the same time as they often are in need of intensive care that includes painful interventions. One of the frequent painful procedures preterm infants undergo is eye examination screening to detect early signs of ROP (retinopathy of prematurity). These examinations are both stressful and painful, and despite a multitude of research studies, no conclusive pain-relieving treatment has been demonstrated. The main aim of this trial is to investigate the analgesic effect of clonidine during ROP eye examinations.

Methods and analysis: The planned study is a multicentre randomised controlled trial with a crossover design. Infants will be recruited from two different neonatal intensive care units (NICUs) in Sweden. Infants born before gestation week 30 (and therefore eligible for ROP screening) and cared for in either of the NICUs will be eligible for inclusion in the study. The primary outcome will be Premature Infant Pain Profile-Revised score within 30 s after starting the examination. Secondary outcomes will be changes in the galvanic skin response parameters (area small peaks, area huge peaks, peaks per second and average rise time) within 30 s after starting the eye examination, together with the number and evaluation of adverse events reported within 72 hours after the examination and the examining physician's assessment of how easy the infant was to examine.

Ethics and dissemination: Approval from the Swedish Ethical Review Authority and the Swedish Medical Products Agency has been obtained for the study. Parents of eligible infants will be getting both verbal and written information about the study including that participation is voluntary. Data will be collected and treated in accordance with the European general data protection regulations. The results will be reported on group level and published in a scientific journal.

Trial registration number: ClinicalTrials.gov (NCT04902859).EudraCT (2021-003005-21).

Keywords: neonatal intensive & critical care; paediatric ophthalmology; pain management.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. Valeri BO, Ranger M, Chau CMY, et al. . Neonatal invasive procedures predict pain intensity at school age in children born very preterm. Clin J Pain 2016;32:1086–93. 10.1097/AJP.0000000000000353
    1. Brummelte S, Grunau RE, Chau V, et al. . Procedural pain and brain development in premature newborns. Ann Neurol 2012;71:385–96. 10.1002/ana.22267
    1. Ranger M, Chau CMY, Garg A, et al. . Neonatal pain-related stress predicts cortical thickness at age 7 years in children born very preterm. PLoS One 2013;8:e76702. 10.1371/journal.pone.0076702
    1. Vinall J, Grunau RE. Impact of repeated procedural pain-related stress in infants born very preterm. Pediatr Res 2014;75:584–7. 10.1038/pr.2014.16
    1. Brummelte S, Chau CMY, Cepeda IL, et al. . Cortisol levels in former preterm children at school age are predicted by neonatal procedural pain-related stress. Psychoneuroendocrinology 2015;51:151–63. 10.1016/j.psyneuen.2014.09.018
    1. Bashinsky AL. Retinopathy of prematurity. N C Med J 2017;78:124–8. 10.18043/ncm.78.2.124
    1. Holmström G, Hellström A, Gränse L, et al. . New modifications of Swedish ROP guidelines based on 10-year data from the SWEDROP register. Br J Ophthalmol 2020;104:943–9. 10.1136/bjophthalmol-2019-314874
    1. Rush R, Rush S, Ighani F, et al. . The effects of comfort care on the pain response in preterm infants undergoing screening for retinopathy of prematurity. Retina 2005;25:59–62. 10.1097/00006982-200501000-00008
    1. Cohen AM, Cook N, Harris MC, et al. . The pain response to mydriatic eyedrops in preterm infants. J Perinatol 2013;33:462–5. 10.1038/jp.2012.149
    1. Olsson E, Eriksson M. Oral glucose for pain relief during eye examinations for retinopathy of prematurity. J Clin Nurs 2011;20:1054–9. 10.1111/j.1365-2702.2010.03529.x
    1. Grabska J, Walden P, Lerer T, et al. . Can oral sucrose reduce the pain and distress associated with screening for retinopathy of prematurity? J Perinatol 2005;25:33–5. 10.1038/sj.jp.7211199
    1. Nesargi SV, Nithyanandam S, Rao S, et al. . Topical anesthesia or oral dextrose for the relief of pain in screening for retinopathy of prematurity: a randomized controlled double-blinded trial. J Trop Pediatr 2015;61:20–4. 10.1093/tropej/fmu058
    1. Gal P, Kissling GE, Young WO, et al. . Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother 2005;39:1029–33. 10.1345/aph.1E477
    1. Dilli D, İlarslan Nisa Eda Çullas, Kabataş EU, et al. . Oral sucrose and non-nutritive sucking goes some way to reducing pain during retinopathy of prematurity eye examinations. Acta Paediatr 2014;103:e76–9. 10.1111/apa.12454
    1. Şener Taplak A, Erdem E. A comparison of breast milk and sucrose in reducing neonatal pain during eye exam for retinopathy of prematurity. Breastfeed Med 2017;12:305–10. 10.1089/bfm.2016.0122
    1. Kristoffersen L, Støen R, Bergseng H, et al. . Skin-to-skin contact during eye examination did not reduce pain compared to standard care with parental support in preterm infants. Acta Paediatr 2019;108:1434–40. 10.1111/apa.14699
    1. Rush R, Rush S, Nicolau J, et al. . Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity. Retina 2004;24:242–5. 10.1097/00006982-200404000-00009
    1. Mandel R, Ali N, Chen J, et al. . Nitrous oxide analgesia during retinopathy screening: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2012;97:F83–7. 10.1136/adc.2011.210740
    1. Hartley C, Moultrie F, Hoskin A, et al. . Analgesic efficacy and safety of morphine in the procedural pain in premature infants (Poppi) study: randomised placebo-controlled trial. Lancet 2018;392:2595–605. 10.1016/S0140-6736(18)31813-0
    1. Sun X, Lemyre B, Barrowman N, et al. . Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review. Acta Paediatr 2010;99:329–34. 10.1111/j.1651-2227.2009.01612.x
    1. Francis K. What is best practice for providing pain relief during retinopathy of prematurity eye examinations? Adv Neonatal Care 2016;16:220–8. 10.1097/ANC.0000000000000267
    1. Disher T, Cameron C, Mitra S, et al. . Pain-Relieving interventions for retinopathy of prematurity: a meta-analysis. Pediatrics 2018;142:1. 10.1542/peds.2018-0401
    1. Pirelli A, Savant Levet P, Garetti E, et al. . Literature review informs clinical guidelines for pain management during screening and laser photocoagulation for retinopathy of prematurity. Acta Paediatr 2019;108:593–9. 10.1111/apa.14523
    1. Läkemedelsverket . Behandling AV barn I samband Med smärtsamma procedurer I hälso- och sjukvård – kunskapsdokument. collected 220424, 2014. Available:
    1. Pichot C, Ghignone M, Quintin L. Dexmedetomidine and clonidine: from second- to first-line sedative agents in the critical care setting? J Intensive Care Med 2012;27:219–37. 10.1177/0885066610396815
    1. Hünseler C, Balling G, Röhlig C, et al. . Continuous infusion of clonidine in ventilated newborns and infants: a randomized controlled trial. Pediatr Crit Care Med 2014;15:512–22. 10.1097/PCC.0000000000000151
    1. Zhang Y. Clonidine preconditioning decreases infarct size and improves neurological outcome from transient forebrain ischemia in the rat. Neuroscience 2004;125:625–31. 10.1016/j.neuroscience.2004.02.011
    1. Stevens BJ, Gibbins S, Yamada J, et al. . The premature infant pain profile-revised (PIPP-R): initial validation and feasibility. Clin J Pain 2014;30:238–43. 10.1097/AJP.0b013e3182906aed
    1. Olsson E, Anderzén-Carlsson A, Atladóttir SM, et al. . Cultural adaptation and harmonization of four Nordic translations of the revised premature infant pain profile (PIPP-R). BMC Pediatr 2018;18:349. 10.1186/s12887-018-1322-5
    1. Storm H. Changes in skin conductance as a tool to monitor nociceptive stimulation and pain. Curr Opin Anaesthesiol 2008;21:796–804. 10.1097/ACO.0b013e3283183fe4
    1. Chan A-W, Tetzlaff JM, Altman DG, et al. . SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200–7. 10.7326/0003-4819-158-3-201302050-00583

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren